HI-6 IN MAN - EFFICACY OF THE OXIME IN POISONING BY ORGANOPHOSPHORUS INSECTICIDES

被引:63
作者
KUSIC, R
JOVANOVIC, D
RANDJELOVIC, S
JOKSOVIC, D
TODOROVIC, V
BOSKOVIC, B
JOKANOVIC, M
VOJVODIC, V
机构
[1] MIL TECH INST,DEPT MED,KATANICEVA 15,YU-11000 BELGRADE,YUGOSLAVIA
[2] MIL MED ACAD,TOXICOL & CLIN PHARMACOL CLIN,YU-11000 BELGRADE,YUGOSLAVIA
来源
HUMAN & EXPERIMENTAL TOXICOLOGY | 1991年 / 10卷 / 02期
关键词
D O I
10.1177/096032719101000204
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The efficacy of the oxime HI-6 was studied as a treatment for organophosphorus poisoning. HI-6 was given four times daily as a single intramuscular injection of 500 mg accompanied by atropine and diazepam therapy. Oxime treatment was started on admission and continued for a minimum of 48 h and a maximum of 7 d. HI-6 rapidly reactivated human blood acetylcholinesterase inhibited by diethoxy organophosphorus compounds, while the dimethoxy-inhibited enzyme was mainly resistant to the treatment by HI-6. Although both HI-6 and pralidoxime chloride reactivated the red blood cell cholinesterase in quinalphos-poisoned subjects, the return of enzyme activities was more rapid following the use of HI-6. The general improvement of poisoned patients, which was sometimes more rapid than the rise of acetylcholinesterase activity, pointed to direct pharmacological effects of HI-6. No undesirable side-effects were noted in patients when HI-6 plasma concentrations were maintained at levels far above the 'therapeutic' concentration for up to 7 d.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 59 条
[1]   MALATHION EXPOSURE ASSOCIATED WITH ACUTE-RENAL-FAILURE [J].
ALBRIGHT, RK ;
KRAM, BW ;
WHITE, RP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (18) :2469-2469
[2]  
ALDRIDGE WN, 1979, ARCH TOXICOL, V42, P95
[3]   THE CHEMICAL BASIS OF THE AGEING PROCESS OF DFP-INHIBITED PSEUDOCHOLINESTERASE [J].
BERENDS, F ;
POSTHUMUS, CH ;
VANDERSLUYS, I ;
DEIERKAUF, FA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1959, 34 (02) :576-578
[4]   RECENT ADVANCES IN TREATMENT OF UNUSUALLY SEVERE POISONING WITH NITROSTIGMINE (E 605 FORTER ) [J].
BOELCKE, G ;
BUTIGAN, N ;
DAVAR, H ;
ERDMANN, WD ;
GAAZ, JW ;
NENNER, M .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1970, 95 (50) :2516-&
[5]  
BOKONJIC D, 1987, ARCH INT PHARMACOD T, V288, P309
[6]  
Boskovic B, 1981, Fundam Appl Toxicol, V1, P203, DOI 10.1016/S0272-0590(81)80059-0
[7]  
Boskovic B., 1984, FUNDAM APPL TOXICOL, V4, P106
[8]  
BOSKOVIC B, 1987, 10TH INT C PHARM SID
[9]   INHIBITION OF HUMAN-PLASMA CHOLINESTERASE BY INGESTED DICHLORVOS - EFFECT OF FORMULATION VEHICLE [J].
BOYER, AC ;
BROWN, LJ ;
SLOMKA, MB ;
HINE, CH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1977, 41 (02) :389-394
[10]  
Clement J G, 1981, Fundam Appl Toxicol, V1, P193, DOI 10.1016/S0272-0590(81)80058-9